Sen. Alexander And The Terrible, Horrible, No Good, Very Bad Reg
This article was originally published in The Pink Sheet Daily
Executive Summary
FDA’s proposed rule to allow generic manufacturers to unilaterally change their labels should be scrapped in favor of congressional action, a group of 28 Republican senators and representatives tells the agency.